COVID-19 in Hemodialysis Patients: A Report of 5 Cases

Published:March 31, 2020DOI:
      In December 2019, an outbreak of coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in China and spread rapidly worldwide. It is unknown whether hemodialysis patients represent a distinct group of patients with certain characteristics that may make them susceptible to infection or severe disease. In this case report, we describe the clinical and epidemiologic features of COVID-19 infection in 201 maintenance hemodialysis patients in Zhongnan Hospital of Wuhan University, including 5 maintenance hemodialysis patients who contracted COVID-19 infection. Of the 5 patients with COVID-19 infection, one had a definite history of contact with an infected person. The age range of the patients was 47 to 67 years. Diarrhea (80%), fever (60%), and fatigue (60%) were the most common symptoms. Lymphopenia occurred in all patients. Computed tomography of the chest showed ground glass opacity in the lungs of all patients. Up to February 13, 2020, none of the patients had developed severe complications (acute respiratory distress syndrome, shock, or multiple organ dysfunction) or died.

      Index Words

      To read this article in full you will need to make a payment


      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. COVID-19 National Incident Room Surveillance Team. COVID-19, Australia: Epidemiology Report 2 (Reporting week ending 19:00 AEDT 8 February 2020).
        Commun Dis Intell (2018). 2020; 44
        • Rolland P.
        • Silue Y.
        • et al.
        First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020.
        Euro Surveill. 2020; 25: 2000094
        • Backer J.A.
        • Klinkenberg D.
        • Wallinga J.
        Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020.
        Euro Surveill. 2020; : 25
        • Liu Y.C.
        • Liao C.H.
        • Chang C.F.
        • Chou C.C.
        • Lin Y.R.
        A locally transmitted case of SARS-CoV-2 infection in Taiwan.
        N Engl J Med. 2020; 382: 1070-1072
        • Bastola A.
        • Sah R.
        • Rodriguez-Morales A.J.
        • et al.
        The first 2019 novel coronavirus case in Nepal.
        Lancet Infect Dis. 2020; 20: 279-280
        • Hui D.S.
        • Azhar E.I.
        • Madani T.A.
        • et al.
        The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China.
        Int J Infect Dis. 2020; 91: 264-266
        • Lu R.
        • Zhao X.
        • Li J.
        • et al.
        Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
        Lancet. 2020; 395: 565-574
        • Ikizler A.
        COVID-19 and dialysis units: what do we know now and what should we do?.
        Am J Kidney Dis. 2020; 76: 1-3
        • Chen N.
        • Zhou M.
        • Dong X.
        • et al.
        Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
        Lancet. 2020; 395: 507-513
        • Liu W.J.
        • Zhao M.
        • Liu K.
        • et al.
        T-cell immunity of SARS-CoV:implications for vaccine development against MERS-CoV.
        Antiviral Res. 2017; 137: 82-92
        • Wong P.N.
        • Mak S.K.
        • Lo K.Y.
        • et al.
        Clinical presentation and outcome of severe acute respiratory syndrome in dialysis patients.
        Am J Kidney Dis. 2003; 42: 1075-1081
        • Pesanti E.L.
        Immunologic defects and vaccination in patients with chronic renal failure.
        Infect Dis Clin North Am. 2001; 15: 813-832
        • Guan W.-j.
        • Ni Z.-y.
        • Hu Y.
        • et al.
        The China Medical Treatment Expert Group for Covid-19. Clinical characteristics of 2019 novel coronavirus infection in China.
        N Engl J Med. 2020; 382: 1708-1720
        • Wang D.
        • Hu B.
        • Hu C.
        • et al.
        Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.
        JAMA. 2020; 323: 1061-1069